Efgartigimod alfa

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Efgartigimod alfa
Treatment and conditionWhere it standsTrials
Efgartigimod alfa for immunoglobulin g4-related diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1